Compassionate Use in Egypt
How the compassionate use pathway operates in Egypt.
About Compassionate Use
A regulatory pathway allowing seriously ill patients access to investigational or unregistered drugs.
How Compassionate Use works in Egypt
Egypt's EDA permits personal-use import of non-registered drugs under physician supervision; process is paperwork-heavy but viable.
Patients in Egypt seeking access under Compassionate Use typically follow this flow: a licensed physician in Egypt issues the prescription and clinical justification, the regulator reviews and authorises, and an authorised operator coordinates import.
Documents required in Egypt
- Physician prescription and clinical-justification letter.
- Patient identification and consent.
- Country-specific NPP/personal-import form.
- Hospital or clinic attestation where required.
Typical timeline
End-to-end 2-6 weeks in most tier 2 jurisdictions. Cellular and gene therapies may require additional ethics-committee review.